increase red cell destruction = reduced red-cell life span

Slides:



Advertisements
Similar presentations
Normocytic Anemia David Lee, MD, FRCPC. Normocytic anemia a heterogenous group of anemias normocytosis implies normal DNA metabolism and hemoglobin synthesis.
Advertisements

Approach to Anemia - Summary
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
In the name of GOD.
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Date : 26/12/2013 Outcome : The student will know : -The types of.
Life of a Red Blood Cell Erythroid precursors undergo 4-5 divisions in marrow, extrude nucleus, become reticulocytes, enter peripheral blood, and survive.
HEMOLYTIC ANEMIA HOSEA NJOKU 1405.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
Hemolytic Anemias due to Other Intracorpuscular Defects
HEMOLYTIC ANEMIAS. HEMOLYTIC ANEMIA Anemia of increased destruction –Normochromic, normochromic anemia –Shortened RBC survival –Reticulocytosis - Response.
Hemolytic anemia HA = decreased levels of erythrocytes in circulating blood (anemia) because of their acclerated destruction (hemolysis) A red blood cell.
 Charachterized by:  A nemia results when the rate of destruction exceeds the capacity of the m arrow to produce RBCs(The bone marro 8 times increased.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Outcome : The student will know : -The types of hemolytic anemias.
Week 2: Hemolytic Anemia
بسم الله الرحمن الرحـيـم
Introduction to Hemolytic Anemias
Classification of Hemolytic anemias I. Red cell abnormality (Intracorpuscular factors) A. Hereditary 1. Membrane defect (spherocytosis, elliptocytosis)
Splenectomy in Hematologic Disorders
Anaemia By Jeeves.
Chapter 11 The Red Blood Cell and Alterations in Oxygen Transport
 The term is derived from ancient Greek ” bloodlessness “it is defined as a low haemoglobin concentration that is below the normal range appropriate.
Glucose-6-phosphate Dehydration Deficiency Nada Mohamed Ahmed, MD, MT (ASCP)i.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof
HEREDITARY/ACQUIRED HEMOLYTIC ANEMIA
Hemolytic Anemias Defined as those anemias result from an increased in the rate of red cell destruction. The red cell destruction is usually removed extravascular.
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
1 Alterations of Hematologic Function in Children Chapter 28.
Haemolytic Anaemia Elliot Catchpole PCMD.
Hemolytic anemia Excessive destruction of red cells Acute Hemolytic anemia Chronic Hemolytic anemia Congenita l Acquired : Immune Non-immune.
MLAB 1415: Hematology Keri Brophy-Martinez
Haemolytic anaemias Dr. Suhair Abbas Ahmed.
Anemia Kristine Krafts, M.D.. Background facts about blood Anemia: general information Anemia: specific types Anemia Outline.
Laboratory evaluation of erythrocyte RBC Haemoglobin Packed cell volume MCV MCH MCHC RDW Reticulocyte Blood film Quantitative description of erythropoiesis.
Acquired haemolytic anaemias
Auto Immune hemolytic anemia
Hemolytic anemias.
 The term is derived from ancient Greek ” bloodlessness “it is defined as a low haemoglobin concentration that is below the normal range appropriate.
MLAB 1415: Hematology Keri Brophy-Martinez Hemolytic Anemia: Nonimmune Defects.
Acquired Haemolytic Anaemias. Haemolytic conditions are those in which: erythrocyte construction industry is healthy (usually) red cells produced have.
HEMOLYTIC ANEMIAS.
Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red cells (reticulocytes)
HEMOLYTIC DESORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red.
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 18: Hemolytic Anemia: Nonimmune Defects.
Glucose-6-phosphate Dehydration Deficiency
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
Done by : Bara Shayib Supervised by : Dr. Abdullateef Alkhateeb.
HEMOLYTIC ANEMIA Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin.
Hemolytic Anemia Part I FJ Albert, DO, DTM&H Hospital Medicine Lexington Medical Center West Columbia, SC Associate Professor Clinical Internal Medicine.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
HAEMOLYTIC ANAEMIA HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam.
Acquired Hemolytic Anemias
1 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Chapter 20. Erythrocytic disorders.
SHEIKHA HEMOLYTIC ANEMIAS. SHEIKHA Abnormalities of the Environment of the Red Cells Abnormalities of the Red Cells Premature destruction of the red cells.
HEMOLYTIC ANEMIA INCREASE RED CELL DESTRUCTION =
By Qassim AI-abody Master in adult nursing
and BLEEDING DISORDERS
MLAB Hematology Fall 2007 Keri Brophy-Martinez
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Anemia By: Dr Sunita Mittal.
HEMOLYTIC DISORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new.
HEMOLYTIC ANEMIA Dr Ramadas Nayak
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
溶血性贫血 Hemolytic Anemia
MLAB 1415-Hematology Keri Brophy-Martinez
CLASSIFICATION OF ANEMIAS
Approach to Haemolysis
Presentation transcript:

increase red cell destruction = reduced red-cell life span HEMOLYTIC ANEMIAS increase red cell destruction = reduced red-cell life span

HEMOLYTIC ANEMIAS A red blood cell survives 90 to 120 days in the circulation; about 1% of human red blood cells break down each day The spleen is the main organ which removes old and damaged RBCs from the circulation

Mechanisms of hemolysis Extravascular red cells destruction occurs in reticuloendothelial system Intravascular red cells destruction occurs in vascular space

Signs of hemolytic anemias Symptoms of anemia – pallor, fatique, rapid pulse Jaundice Splenomegaly

Diagnosis of hemolytic anemias Reticulocytosis Indirect hyperbilirubinemia Increased level of lactate dehydrogenase (LDH) Absence or reduced of free serum haptoglobin

INtravascular hemolysis laboratory signs of intravascular hemolysis: - tests for hemolysis and aditionally: - hemoglobinemia - hemoglobinuria - hemosiderynuria

hemolytic anemias Compensated hemolysis – increase erythropoesis compensates increase destruction of erythrocytes Decompensated hemolysis - erythropoesis can not compensates increae destruction – patient needs therapy

Complications of increased, chronic hemolysis Folinic acid deficiency Gallstones Thrombosis Hemolytic crisis - rapid destruction of large numbers of red blood cells

Classification of hemolytic anemias Hereditary Membrane defect (spherocytosis, elliptocytosis) Metabolic defect (Glucoze-6-Phosphate-Dehydrogenaze (G6PD) deficiency, Pyruvate kinase (PK) deficiency) Hemoglobinopathies (thalassemias, sickle cell anemia ) Acquired Immune hemolytic anemias Nonimmune hemolytic anemias

Hereditary membrane defects Spherocytosis The most common defect of red cell membrane protein (1/2000 birth) Inheritance - autosomal dominant Deficient of membrane protein causes change of shape (round, no central pallor) Clinical features: jaundice, gallstones, splenomegaly, constitutional skeleton changes (ie tower cranium, gothic palate) Laboratory features: anemia, hiperbilirubinemia, retikulocytosis,  LDH - blood smear - microspherocytes - abnormal osmotic fragility test Treatment - splenectomy

Spherocytes

Hereditary membrane defects Elliptocytosis

Hereditary metabolic defect Glucoze-6-Phosphate-Dehydrogenaze (G6PD) deficiency Hemolysis is induce by infections, drugs Hemolysis is intravascular Pyruvate kinase (PK) deficiency

Hereditary Hemoglobinopathies Thalassemias Alfa thalassemia Beta thalasemia: major, minor (trait), intermedia Delta/Beta thalassemia Hereditary persistentce of fetal hemoglobin Sickle cell anemia

SICKLE CELL ANEMIA Definition: chronic hemolytic anemia characterized by sickle-shaped red cells caused by homozygous inheritance of Hemoglobin S

SICKLE CELL ANEMIA - incidence - Occurs mainly in people of African, Caribbean, Mediterranean descent - Homozygous - about 0,3% of Arficans Americans in the USA (have sickle cell anemia) Hetezygotes-8-13% of Africans Americans (are not anemic, but the sickling trait = sicklemia can be demonstrated in vitro)

SICKLE CELL ANEMIA-pathogenesis - Hemolysis - because sickle RBCs are too fragile to withstand the mechanical trauma of circulation - Occlusion in microvascular circulation caused by distorted, inflexible RBCs adhering to vascular endothelium

SICKLE CELL ANEMIA - clinical features IN HOMOZYGOTES Onset in the first or second year of live Period episodes of acute vascular occlussion (painful crisis) Consequences of vaso-occlusion of the microcirculations (tissue ischemia and infarction) - infarction of spleen, brain, marrow, kidney, lung, aseptic necrosis, central nervous system and ophtalmic vascular lesions Events which impair tissue oxygenation can precipitate crisis (f.e. pneumonia)

SICKLE CELL ANEMIA-therapy Preventive measures: prevention or remedy of: infections (penicillin prophylaxis and pneumococcal vaccination), fever, dehydratation,acidosis, hypoxemia, cold exposure Blood transfusions for very severe anemia New approaches to therapy; 1. Activation of Hb F synthesis - 5-azacytidine 2. Antisickling agents acting on hemoglobin or membrane 3. Bone marrow transplantation

2. Acquired A. Immune hemolytic anemias 1. Autoimmune hemolytic anemia - caused by warm-reactive antibodies - caused by cold-reactive antibodies 2. Alloimmune hemolytic anemia (transfusion of incompatible blood) B. Nonimmune hemolytic anemias 1. Chemicals 2. Bacterial infections, parasitic infections (malaria) 3. Hemolysis due to physical trauma (e.g. microangiopathic hemolytic anemia) 4. Hypersplenism 5. Paroxysmal nocturnal hemoglobinuria (PNH)

Autoimmune hemolytic anemia - AIHA caused by warm-reactive antibodies (70%) - infections, connective tissue disorders, drugs caused by cold-reactive antibodies (30%) – in temp. < 37 (4°) - infections, CLL, NHL Laboratory findings: direct Coombs test (direct antiglobulin test) Treatment: underlying disease, steroids, immunosupresive Avoid RBC transfusions

2. Acquired Immune hemolytic anemias 1. Autoimmune hemolytic anemia - caused by warm-reactive antibodies - caused by cold-reactive antibodies 2. Alloimmune hemolytic anemia B. Nonimmune hemolytic anemias 1. Chemicals 2. Bacterial infections, parasitic infections (malaria) 3. Hemolysis due to physical trauma (e.g. microangiopathic hemolytic anemia) 4. Hypersplenism 5. Paroxysmal nocturnal hemoglobinuria (PNH)

Alloimmune hemolytic anemia Transfusion of incompatible blood Serologic incompatibility After transplantation of bone marrow or organs

2. Acquired Immune hemolytic anemias 1. Autoimmune hemolytic anemia - caused by warm-reactive antibodies - caused by cold-reactive antibodies 2. Alloimmune hemolytic anemia B. Nonimmune hemolytic anemias 1. Chemicals 2. Bacterial infections, parasitic infections (malaria) 3. Hemolysis due to physical trauma - microangiopathic hemolytic anemia 4. Hypersplenism 5. Paroxysmal nocturnal hemoglobinuria (PNH)

Classification of microangiopathic hemolytic anemia Thrombotic thrombocytopenic purpura (TTP) Hemolytic uremic syndrome (HUS)

Microangiopathic hemolytic anemia Intravascular hemolysis caused by fragmentation of normal red cells passing through abnormal arterioles Arterioles are changed by deposition of platelets and fibrin Microvascular lesion cause organ demage (kidney, CNS)

Microangiopathic hemolytic anaemia Underlying disease Invasive carcinoma Complication of pregnancy Serious infection Drugs

Microangiopathic hemolytic anaemia Symptoms: Related to the primary disease Related to organs demage Laboratory findings Blood film: schistocytes

2. Acquired Immune hemolytic anemias 1. Autoimmune hemolytic anemia - caused by warm-reactive antibodies - caused by cold-reactive antibodies 2. Transfusion of incompatible blood B. Nonimmune hemolytic anemias 1. Chemicals 2. Bacterial infections, parasitic infections (malaria) 3. Hemolysis due to physical trauma - hemolytic - uremic syndrome (HUS) - thrombotic thrombocytopenic purpura (TTP) - prosthetic heart valves 4. Hypersplenism 5. Paroxysmal nocturnal hemoglobinuria (PNH)

Hypersplenism State of hyperactivity of the spleen Causes of hypersplenism Infection – bacterial, viruses, fungi Inflammatory diseases - Neoplasm Storage disorders (Gaucher disease) Other – amyloidosis, sarcoidosis

2. Acquired Immune hemolytic anemias 1. Autoimmune hemolytic anemia - caused by warm-reactive antibodies - caused by cold-reactive antibodies 2. Transfusion of incompatible blood B. Nonimmune hemolytic anemias 1. Chemicals 2. Bacterial infections, parasitic infections (malaria) 3. Hemolysis due to physical trauma - hemolytic - uremic syndrome (HUS) - thrombotic thrombocytopenic purpura (TTP) - prosthetic heart valves 4. Hypersplenism 5. Paroxysmal nocturnal hemoglobinuria (PNH)

Paroxysmal nocturnal hemoglobinuria (PNH) Pathogenesis - an acquired clonal disease, arising from a somatic mutation in a single abnormal stem cell - deficiency of the GPI (glycosyl-phosphatidyl-inositol) anchor on the surface of hematopoietic cells - red cells are more sensitive to the lytic effect of complement - intravascular hemolysis

Paroxysmal nocturnal hemoglobinuria (PNH) Symptoms Irregularly hemoglobinuria occurs with dark brown urine in the morning Hemolysis is released by infection, surgery or other events Increased risk of thrombosis Renal failure Neurologic manifestation - headaches

Paroxysmal nocturnal hemoglobinuria (PNH) Laboratory features - hemoglobinuria - hemosiderinuria - pancytopenia - chronic urinary iron loss - serum iron concentration decreased - positive Ham’s test (acid hemolysis test) - specific immunophenotype of erytrocytes (CD59, CD55)

Paroxysmal nocturnal hemoglobinuria (PNH) Treatment - washed RBC transfusion - iron therapy - allogenic bone marrow transplantation Monoclonal antibody Eculizumab (trade name Soliris)

What do you have to remember Anemia + Retikulocytosis  bilirubin (unconjugated),  LDH  haptoglobin Haemoglobin and haemosiderin in urine